nodes	percent_of_prediction	percent_of_DWPC	metapath
Levomilnacipran—SLC6A4—bipolar disorder	0.851	1	CbGaD
Levomilnacipran—SLC6A2—locus ceruleus—bipolar disorder	0.0194	0.22	CbGeAlD
Levomilnacipran—SLC6A2—autonomic nervous system—bipolar disorder	0.0103	0.117	CbGeAlD
Levomilnacipran—CYP2C19—urine—bipolar disorder	0.00792	0.0897	CbGeAlD
Levomilnacipran—SLC6A4—blood plasma—bipolar disorder	0.00499	0.0565	CbGeAlD
Levomilnacipran—CYP3A4—urine—bipolar disorder	0.00468	0.0531	CbGeAlD
Levomilnacipran—CYP2D6—urine—bipolar disorder	0.00461	0.0522	CbGeAlD
Levomilnacipran—CYP2C19—blood plasma—bipolar disorder	0.00413	0.0468	CbGeAlD
Levomilnacipran—Pethidine—GRIN1—bipolar disorder	0.00364	0.279	CrCbGaD
Levomilnacipran—CYP2C8—blood plasma—bipolar disorder	0.00361	0.0409	CbGeAlD
Levomilnacipran—CYP2J2—thyroid gland—bipolar disorder	0.00327	0.0371	CbGeAlD
Levomilnacipran—Milnacipran—SLC6A4—bipolar disorder	0.00305	0.234	CrCbGaD
Levomilnacipran—CYP2J2—nervous system—bipolar disorder	0.00275	0.0312	CbGeAlD
Levomilnacipran—CYP2J2—cerebellum—bipolar disorder	0.00259	0.0293	CbGeAlD
Levomilnacipran—CYP3A4—blood plasma—bipolar disorder	0.00244	0.0277	CbGeAlD
Levomilnacipran—CYP2D6—blood plasma—bipolar disorder	0.0024	0.0272	CbGeAlD
Levomilnacipran—Diethylpropion—SLC6A3—bipolar disorder	0.00227	0.174	CrCbGaD
Levomilnacipran—Pethidine—GRIN2B—bipolar disorder	0.00224	0.171	CrCbGaD
Levomilnacipran—CYP2J2—brain—bipolar disorder	0.0021	0.0238	CbGeAlD
Levomilnacipran—ABCB1—blood plasma—bipolar disorder	0.00173	0.0196	CbGeAlD
Levomilnacipran—SLC6A4—nervous system—bipolar disorder	0.00148	0.0168	CbGeAlD
Levomilnacipran—SLC6A2—nervous system—bipolar disorder	0.00131	0.0148	CbGeAlD
Levomilnacipran—SLC6A2—Na+/Cl- dependent neurotransmitter transporters—SLC6A3—bipolar disorder	0.00117	0.0244	CbGpPWpGaD
Levomilnacipran—SLC6A4—brain—bipolar disorder	0.00113	0.0128	CbGeAlD
Levomilnacipran—SLC6A2—Monoamine Transport—TPH2—bipolar disorder	0.00108	0.0225	CbGpPWpGaD
Levomilnacipran—Pethidine—SLC6A3—bipolar disorder	0.00106	0.081	CrCbGaD
Levomilnacipran—SLC6A2—brain—bipolar disorder	0.000998	0.0113	CbGeAlD
Levomilnacipran—SLC6A4—SIDS Susceptibility Pathways—POU3F2—bipolar disorder	0.000959	0.0199	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metapathway biotransformation—AKR1C4—bipolar disorder	0.000951	0.0198	CbGpPWpGaD
Levomilnacipran—SLC6A4—Monoamine Transport—SLC6A3—bipolar disorder	0.000899	0.0187	CbGpPWpGaD
Levomilnacipran—ABCB1—adrenal cortex—bipolar disorder	0.000878	0.00995	CbGeAlD
Levomilnacipran—SLC6A2—Monoamine Transport—SLC6A4—bipolar disorder	0.000867	0.018	CbGpPWpGaD
Levomilnacipran—SLC6A4—Serotonin Transporter Activity—IL1B—bipolar disorder	0.000861	0.0179	CbGpPWpGaD
Levomilnacipran—CYP2C8—brain—bipolar disorder	0.00082	0.00929	CbGeAlD
Levomilnacipran—SLC6A2—Amine compound SLC transporters—SLC6A3—bipolar disorder	0.000814	0.0169	CbGpPWpGaD
Levomilnacipran—Pethidine—SLC6A4—bipolar disorder	0.00079	0.0606	CrCbGaD
Levomilnacipran—SLC6A2—Monoamine Transport—SLC6A3—bipolar disorder	0.000773	0.0161	CbGpPWpGaD
Levomilnacipran—CYP3A4—nervous system—bipolar disorder	0.000727	0.00823	CbGeAlD
Levomilnacipran—CYP2D6—nervous system—bipolar disorder	0.000715	0.0081	CbGeAlD
Levomilnacipran—SLC6A4—Synaptic Vesicle Pathway—SNAP25—bipolar disorder	0.000694	0.0144	CbGpPWpGaD
Levomilnacipran—CYP2D6—cerebellum—bipolar disorder	0.000673	0.00762	CbGeAlD
Levomilnacipran—CYP2J2—Phase 1 - Functionalization of compounds—MAOA—bipolar disorder	0.000648	0.0135	CbGpPWpGaD
Levomilnacipran—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC5A3—bipolar disorder	0.000634	0.0132	CbGpPWpGaD
Levomilnacipran—ABCB1—thyroid gland—bipolar disorder	0.000611	0.00693	CbGeAlD
Levomilnacipran—CYP2D6—brain—bipolar disorder	0.000547	0.00619	CbGeAlD
Levomilnacipran—CYP2C19—Melatonin metabolism and effects—CLOCK—bipolar disorder	0.000543	0.0113	CbGpPWpGaD
Levomilnacipran—SLC6A4—NRF2 pathway—SLC5A3—bipolar disorder	0.000531	0.011	CbGpPWpGaD
Levomilnacipran—CYP2J2—Cytochrome P450 - arranged by substrate type—POMC—bipolar disorder	0.00052	0.0108	CbGpPWpGaD
Levomilnacipran—ABCB1—nervous system—bipolar disorder	0.000514	0.00583	CbGeAlD
Levomilnacipran—CYP2D6—Melatonin metabolism and effects—CLOCK—bipolar disorder	0.0005	0.0104	CbGpPWpGaD
Levomilnacipran—ABCB1—cerebellum—bipolar disorder	0.000484	0.00548	CbGeAlD
Levomilnacipran—SLC6A2—NRF2 pathway—SLC5A3—bipolar disorder	0.000457	0.0095	CbGpPWpGaD
Levomilnacipran—SLC6A4—Circadian rythm related genes—NR1D1—bipolar disorder	0.000439	0.00913	CbGpPWpGaD
Levomilnacipran—CYP2J2—Phase 1 - Functionalization of compounds—POMC—bipolar disorder	0.000422	0.00876	CbGpPWpGaD
Levomilnacipran—ABCB1—brain—bipolar disorder	0.000393	0.00446	CbGeAlD
Levomilnacipran—SLC6A4—SIDS Susceptibility Pathways—GRIN1—bipolar disorder	0.00039	0.0081	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism of lipids and lipoproteins—AKR1C4—bipolar disorder	0.00037	0.00769	CbGpPWpGaD
Levomilnacipran—SLC6A4—Monoamine Transport—IL1B—bipolar disorder	0.000367	0.00762	CbGpPWpGaD
Levomilnacipran—SLC6A4—SIDS Susceptibility Pathways—TPH2—bipolar disorder	0.000355	0.00738	CbGpPWpGaD
Levomilnacipran—SLC6A4—SIDS Susceptibility Pathways—TACR1—bipolar disorder	0.000355	0.00738	CbGpPWpGaD
Levomilnacipran—SLC6A4—NRF2 pathway—SERPINA1—bipolar disorder	0.000352	0.00732	CbGpPWpGaD
Levomilnacipran—CYP2J2—Biological oxidations—COMT—bipolar disorder	0.000346	0.0072	CbGpPWpGaD
Levomilnacipran—CYP2J2—Biological oxidations—MAOA—bipolar disorder	0.000344	0.00715	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metapathway biotransformation—COMT—bipolar disorder	0.000342	0.0071	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism of lipids and lipoproteins—NR1D1—bipolar disorder	0.000333	0.00691	CbGpPWpGaD
Levomilnacipran—CYP2C19—Melatonin metabolism and effects—MAOA—bipolar disorder	0.000318	0.00662	CbGpPWpGaD
Levomilnacipran—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A3—bipolar disorder	0.000318	0.00661	CbGpPWpGaD
Levomilnacipran—SLC6A2—Monoamine Transport—IL1B—bipolar disorder	0.000315	0.00655	CbGpPWpGaD
Levomilnacipran—SLC6A2—NRF2 pathway—SERPINA1—bipolar disorder	0.000303	0.00629	CbGpPWpGaD
Levomilnacipran—SLC6A4—Circadian rythm related genes—CLOCK—bipolar disorder	0.000298	0.00618	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism—IMPA2—bipolar disorder	0.000296	0.00616	CbGpPWpGaD
Levomilnacipran—SLC6A4—SIDS Susceptibility Pathways—HTR1A—bipolar disorder	0.000294	0.00611	CbGpPWpGaD
Levomilnacipran—CYP2D6—Melatonin metabolism and effects—MAOA—bipolar disorder	0.000293	0.00609	CbGpPWpGaD
Levomilnacipran—SLC6A4—Circadian rythm related genes—TPH2—bipolar disorder	0.00029	0.00602	CbGpPWpGaD
Levomilnacipran—SLC6A4—SIDS Susceptibility Pathways—TAC1—bipolar disorder	0.000289	0.00602	CbGpPWpGaD
Levomilnacipran—SLC6A2—SLC-mediated transmembrane transport—SLC5A3—bipolar disorder	0.000288	0.00599	CbGpPWpGaD
Levomilnacipran—SLC6A4—SIDS Susceptibility Pathways—SNAP25—bipolar disorder	0.000284	0.0059	CbGpPWpGaD
Levomilnacipran—SLC6A4—SIDS Susceptibility Pathways—GATA3—bipolar disorder	0.000284	0.0059	CbGpPWpGaD
Levomilnacipran—CYP3A4—Estrogen metabolism—COMT—bipolar disorder	0.000282	0.00587	CbGpPWpGaD
Levomilnacipran—SLC6A4—SIDS Susceptibility Pathways—NTRK2—bipolar disorder	0.000276	0.00574	CbGpPWpGaD
Levomilnacipran—ABCB1—HIF-1-alpha transcription factor network—ADM—bipolar disorder	0.000275	0.00571	CbGpPWpGaD
Levomilnacipran—SLC6A4—NRF2 pathway—SLC6A3—bipolar disorder	0.000267	0.00554	CbGpPWpGaD
Levomilnacipran—SLC6A2—NRF2 pathway—SLC6A4—bipolar disorder	0.000257	0.00535	CbGpPWpGaD
Levomilnacipran—SLC6A2—Transmembrane transport of small molecules—TRPM2—bipolar disorder	0.000255	0.0053	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metapathway biotransformation—AKR1C4—bipolar disorder	0.000237	0.00493	CbGpPWpGaD
Levomilnacipran—SLC6A4—Circadian rythm related genes—DRD1—bipolar disorder	0.000232	0.00482	CbGpPWpGaD
Levomilnacipran—SLC6A2—NRF2 pathway—SLC6A3—bipolar disorder	0.000229	0.00477	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism of lipids and lipoproteins—CLOCK—bipolar disorder	0.000225	0.00468	CbGpPWpGaD
Levomilnacipran—SLC6A4—Circadian rythm related genes—DRD3—bipolar disorder	0.000224	0.00466	CbGpPWpGaD
Levomilnacipran—CYP2J2—Biological oxidations—POMC—bipolar disorder	0.000224	0.00465	CbGpPWpGaD
Levomilnacipran—SLC6A4—Circadian rythm related genes—DRD4—bipolar disorder	0.000218	0.00453	CbGpPWpGaD
Levomilnacipran—SLC6A4—SIDS Susceptibility Pathways—MAOA—bipolar disorder	0.000214	0.00444	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metapathway biotransformation—AKR1C4—bipolar disorder	0.000212	0.0044	CbGpPWpGaD
Levomilnacipran—CYP2C19—Melatonin metabolism and effects—GSK3B—bipolar disorder	0.000209	0.00434	CbGpPWpGaD
Levomilnacipran—SLC6A4—SIDS Susceptibility Pathways—BDNF—bipolar disorder	0.000206	0.00428	CbGpPWpGaD
Levomilnacipran—SLC6A4—NRF2 pathway—NRG1—bipolar disorder	0.000204	0.00423	CbGpPWpGaD
Levomilnacipran—SLC6A4—Circadian rythm related genes—DRD2—bipolar disorder	0.000203	0.00422	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism—IMPA1—bipolar disorder	0.0002	0.00416	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism of lipids and lipoproteins—PIK3C2A—bipolar disorder	0.000196	0.00407	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metapathway biotransformation—AKR1C4—bipolar disorder	0.000195	0.00405	CbGpPWpGaD
Levomilnacipran—CYP2D6—Melatonin metabolism and effects—GSK3B—bipolar disorder	0.000192	0.00399	CbGpPWpGaD
Levomilnacipran—SLC6A4—Circadian rythm related genes—NTRK1—bipolar disorder	0.000184	0.00382	CbGpPWpGaD
Levomilnacipran—SLC6A4—SIDS Susceptibility Pathways—NR3C1—bipolar disorder	0.000182	0.00378	CbGpPWpGaD
Levomilnacipran—SLC6A2—NRF2 pathway—NRG1—bipolar disorder	0.000175	0.00364	CbGpPWpGaD
Levomilnacipran—SLC6A4—SIDS Susceptibility Pathways—HTR2A—bipolar disorder	0.000174	0.00362	CbGpPWpGaD
Levomilnacipran—ABCB1—Allograft Rejection—HLA-E—bipolar disorder	0.000171	0.00356	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism—NDUFV2—bipolar disorder	0.00017	0.00354	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism—AKR1C4—bipolar disorder	0.000165	0.00343	CbGpPWpGaD
Levomilnacipran—CYP2C8—Phase 1 - Functionalization of compounds—MAOA—bipolar disorder	0.000162	0.00336	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism—NR1D1—bipolar disorder	0.000148	0.00308	CbGpPWpGaD
Levomilnacipran—SLC6A2—Transmembrane transport of small molecules—SLC5A3—bipolar disorder	0.000146	0.00304	CbGpPWpGaD
Levomilnacipran—SLC6A2—SLC-mediated transmembrane transport—SLC6A3—bipolar disorder	0.000145	0.003	CbGpPWpGaD
Levomilnacipran—CYP2C19—Phase 1 - Functionalization of compounds—MAOA—bipolar disorder	0.000144	0.003	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism—NCAN—bipolar disorder	0.000142	0.00294	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism—SLC5A3—bipolar disorder	0.000139	0.00288	CbGpPWpGaD
Levomilnacipran—CYP2D6—Phase 1 - Functionalization of compounds—MAOA—bipolar disorder	0.000133	0.00276	CbGpPWpGaD
Levomilnacipran—CYP2C8—Cytochrome P450 - arranged by substrate type—POMC—bipolar disorder	0.00013	0.0027	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metapathway biotransformation—AKR1C4—bipolar disorder	0.000127	0.00265	CbGpPWpGaD
Levomilnacipran—CYP2C19—Cytochrome P450 - arranged by substrate type—POMC—bipolar disorder	0.000116	0.00241	CbGpPWpGaD
Levomilnacipran—SLC6A4—Circadian rythm related genes—GSK3B—bipolar disorder	0.000114	0.00238	CbGpPWpGaD
Levomilnacipran—ABCB1—Transmembrane transport of small molecules—TRPM2—bipolar disorder	0.000112	0.00233	CbGpPWpGaD
Levomilnacipran—SLC6A2—Transmembrane transport of small molecules—TRPC3—bipolar disorder	0.000111	0.0023	CbGpPWpGaD
Levomilnacipran—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—bipolar disorder	0.000107	0.00221	CbGpPWpGaD
Levomilnacipran—CYP2C8—Phase 1 - Functionalization of compounds—POMC—bipolar disorder	0.000105	0.00219	CbGpPWpGaD
Levomilnacipran—SLC6A4—SIDS Susceptibility Pathways—IL1B—bipolar disorder	0.000103	0.00214	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism—CLOCK—bipolar disorder	0.0001	0.00209	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism—TSHB—bipolar disorder	9.78e-05	0.00203	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism—TPH2—bipolar disorder	9.78e-05	0.00203	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism—CACNB2—bipolar disorder	9.78e-05	0.00203	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism—DPYD—bipolar disorder	9.62e-05	0.002	CbGpPWpGaD
Levomilnacipran—CYP2C19—Phase 1 - Functionalization of compounds—POMC—bipolar disorder	9.39e-05	0.00195	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism of lipids and lipoproteins—AKR1C4—bipolar disorder	9.24e-05	0.00192	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism—CACNA1C—bipolar disorder	8.94e-05	0.00186	CbGpPWpGaD
Levomilnacipran—ABCB1—Integrated Pancreatic Cancer Pathway—GSK3A—bipolar disorder	8.82e-05	0.00183	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism—PIK3C2A—bipolar disorder	8.72e-05	0.00181	CbGpPWpGaD
Levomilnacipran—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—bipolar disorder	8.68e-05	0.0018	CbGpPWpGaD
Levomilnacipran—CYP2C8—Biological oxidations—COMT—bipolar disorder	8.65e-05	0.0018	CbGpPWpGaD
Levomilnacipran—CYP2D6—Phase 1 - Functionalization of compounds—POMC—bipolar disorder	8.64e-05	0.0018	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism of lipids and lipoproteins—POMC—bipolar disorder	8.6e-05	0.00179	CbGpPWpGaD
Levomilnacipran—CYP2C8—Biological oxidations—MAOA—bipolar disorder	8.59e-05	0.00178	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metapathway biotransformation—COMT—bipolar disorder	8.53e-05	0.00177	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism of lipids and lipoproteins—NR1D1—bipolar disorder	8.3e-05	0.00173	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism of lipids and lipoproteins—AKR1C4—bipolar disorder	8.25e-05	0.00171	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism—SNAP25—bipolar disorder	7.82e-05	0.00162	CbGpPWpGaD
Levomilnacipran—CYP2C19—Biological oxidations—COMT—bipolar disorder	7.72e-05	0.0016	CbGpPWpGaD
Levomilnacipran—CYP2C19—Biological oxidations—MAOA—bipolar disorder	7.66e-05	0.00159	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metapathway biotransformation—COMT—bipolar disorder	7.61e-05	0.00158	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism of lipids and lipoproteins—NR1D1—bipolar disorder	7.41e-05	0.00154	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—IMPA2—bipolar disorder	7.4e-05	0.00154	CbGpPWpGaD
Levomilnacipran—SLC6A2—Transmembrane transport of small molecules—SLC6A3—bipolar disorder	7.35e-05	0.00153	CbGpPWpGaD
Levomilnacipran—SLC6A2—Transmembrane transport of small molecules—ADCY2—bipolar disorder	7.3e-05	0.00152	CbGpPWpGaD
Levomilnacipran—ABCB1—Integrated Pancreatic Cancer Pathway—NTRK1—bipolar disorder	7.25e-05	0.00151	CbGpPWpGaD
Levomilnacipran—CYP2D6—Biological oxidations—COMT—bipolar disorder	7.1e-05	0.00148	CbGpPWpGaD
Levomilnacipran—CYP2D6—Biological oxidations—MAOA—bipolar disorder	7.05e-05	0.00147	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metapathway biotransformation—COMT—bipolar disorder	7e-05	0.00146	CbGpPWpGaD
Levomilnacipran—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—bipolar disorder	6.97e-05	0.00145	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism—ADCY2—bipolar disorder	6.92e-05	0.00144	CbGpPWpGaD
Levomilnacipran—ABCB1—Allograft Rejection—IL1B—bipolar disorder	6.74e-05	0.0014	CbGpPWpGaD
Levomilnacipran—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—bipolar disorder	6.64e-05	0.00138	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—IMPA2—bipolar disorder	6.61e-05	0.00137	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—IMPA2—bipolar disorder	6.45e-05	0.00134	CbGpPWpGaD
Levomilnacipran—ABCB1—Transmembrane transport of small molecules—SLC5A3—bipolar disorder	6.44e-05	0.00134	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—IMPA2—bipolar disorder	6.08e-05	0.00126	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism—COMT—bipolar disorder	5.92e-05	0.00123	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism—MAOA—bipolar disorder	5.88e-05	0.00122	CbGpPWpGaD
Levomilnacipran—CYP3A4—Phase 1 - Functionalization of compounds—POMC—bipolar disorder	5.65e-05	0.00117	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism of lipids and lipoproteins—CLOCK—bipolar disorder	5.62e-05	0.00117	CbGpPWpGaD
Levomilnacipran—CYP2C8—Biological oxidations—POMC—bipolar disorder	5.59e-05	0.00116	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism of lipids and lipoproteins—CLOCK—bipolar disorder	5.02e-05	0.00104	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—IMPA1—bipolar disorder	5e-05	0.00104	CbGpPWpGaD
Levomilnacipran—CYP2C19—Biological oxidations—POMC—bipolar disorder	4.99e-05	0.00104	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism of lipids and lipoproteins—PIK3C2A—bipolar disorder	4.89e-05	0.00102	CbGpPWpGaD
Levomilnacipran—ABCB1—Transmembrane transport of small molecules—TRPC3—bipolar disorder	4.88e-05	0.00101	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism—MTHFR—bipolar disorder	4.79e-05	0.000995	CbGpPWpGaD
Levomilnacipran—CYP3A4—Biological oxidations—COMT—bipolar disorder	4.64e-05	0.000965	CbGpPWpGaD
Levomilnacipran—CYP3A4—Biological oxidations—MAOA—bipolar disorder	4.61e-05	0.000958	CbGpPWpGaD
Levomilnacipran—CYP2D6—Biological oxidations—POMC—bipolar disorder	4.59e-05	0.000954	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metapathway biotransformation—COMT—bipolar disorder	4.58e-05	0.000951	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—IMPA1—bipolar disorder	4.46e-05	0.000927	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism of lipids and lipoproteins—PIK3C2A—bipolar disorder	4.36e-05	0.000906	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—IMPA1—bipolar disorder	4.35e-05	0.000905	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—NDUFV2—bipolar disorder	4.25e-05	0.000883	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—AKR1C4—bipolar disorder	4.12e-05	0.000855	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—IMPA1—bipolar disorder	4.1e-05	0.000853	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—IMPA2—bipolar disorder	3.97e-05	0.000825	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism—POMC—bipolar disorder	3.83e-05	0.000796	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism—INS—bipolar disorder	3.81e-05	0.000791	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—NDUFV2—bipolar disorder	3.79e-05	0.000788	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—NDUFV2—bipolar disorder	3.7e-05	0.000769	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—NR1D1—bipolar disorder	3.7e-05	0.000768	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—AKR1C4—bipolar disorder	3.67e-05	0.000764	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—AKR1C4—bipolar disorder	3.59e-05	0.000745	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—NCAN—bipolar disorder	3.54e-05	0.000735	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—NDUFV2—bipolar disorder	3.49e-05	0.000725	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—SLC5A3—bipolar disorder	3.46e-05	0.00072	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—AKR1C4—bipolar disorder	3.38e-05	0.000702	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—NR1D1—bipolar disorder	3.3e-05	0.000686	CbGpPWpGaD
Levomilnacipran—ABCB1—Transmembrane transport of small molecules—SLC6A3—bipolar disorder	3.24e-05	0.000672	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—NR1D1—bipolar disorder	3.22e-05	0.000669	CbGpPWpGaD
Levomilnacipran—ABCB1—Transmembrane transport of small molecules—ADCY2—bipolar disorder	3.21e-05	0.000668	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—NCAN—bipolar disorder	3.16e-05	0.000656	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—SLC5A3—bipolar disorder	3.09e-05	0.000643	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—NCAN—bipolar disorder	3.08e-05	0.00064	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—NR1D1—bipolar disorder	3.04e-05	0.000631	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—SLC5A3—bipolar disorder	3.02e-05	0.000627	CbGpPWpGaD
Levomilnacipran—CYP3A4—Biological oxidations—POMC—bipolar disorder	3e-05	0.000624	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—NCAN—bipolar disorder	2.9e-05	0.000603	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—SLC5A3—bipolar disorder	2.84e-05	0.000591	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—IMPA1—bipolar disorder	2.68e-05	0.000558	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—CLOCK—bipolar disorder	2.5e-05	0.000521	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—TSHB—bipolar disorder	2.44e-05	0.000507	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—TPH2—bipolar disorder	2.44e-05	0.000507	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—CACNB2—bipolar disorder	2.44e-05	0.000507	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—DPYD—bipolar disorder	2.4e-05	0.000499	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—NDUFV2—bipolar disorder	2.28e-05	0.000474	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—CLOCK—bipolar disorder	2.24e-05	0.000465	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—CACNA1C—bipolar disorder	2.23e-05	0.000464	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—AKR1C4—bipolar disorder	2.21e-05	0.000459	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—CLOCK—bipolar disorder	2.18e-05	0.000454	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—TSHB—bipolar disorder	2.18e-05	0.000453	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—TPH2—bipolar disorder	2.18e-05	0.000453	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—CACNB2—bipolar disorder	2.18e-05	0.000453	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—PIK3C2A—bipolar disorder	2.18e-05	0.000452	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism of lipids and lipoproteins—POMC—bipolar disorder	2.15e-05	0.000446	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—DPYD—bipolar disorder	2.14e-05	0.000445	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—TSHB—bipolar disorder	2.13e-05	0.000442	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—TPH2—bipolar disorder	2.13e-05	0.000442	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—CACNB2—bipolar disorder	2.13e-05	0.000442	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—DPYD—bipolar disorder	2.09e-05	0.000435	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—CLOCK—bipolar disorder	2.06e-05	0.000427	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—TPH2—bipolar disorder	2e-05	0.000416	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—CACNB2—bipolar disorder	2e-05	0.000416	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—TSHB—bipolar disorder	2e-05	0.000416	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—CACNA1C—bipolar disorder	1.99e-05	0.000414	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—NR1D1—bipolar disorder	1.98e-05	0.000412	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—DPYD—bipolar disorder	1.97e-05	0.00041	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—SNAP25—bipolar disorder	1.95e-05	0.000406	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—CACNA1C—bipolar disorder	1.95e-05	0.000404	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—PIK3C2A—bipolar disorder	1.94e-05	0.000404	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism of lipids and lipoproteins—POMC—bipolar disorder	1.92e-05	0.000398	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—NCAN—bipolar disorder	1.9e-05	0.000394	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—PIK3C2A—bipolar disorder	1.9e-05	0.000394	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—SLC5A3—bipolar disorder	1.86e-05	0.000386	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—CACNA1C—bipolar disorder	1.83e-05	0.000381	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—PIK3C2A—bipolar disorder	1.79e-05	0.000371	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—SNAP25—bipolar disorder	1.74e-05	0.000362	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—ADCY2—bipolar disorder	1.73e-05	0.000359	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—SNAP25—bipolar disorder	1.7e-05	0.000353	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—SNAP25—bipolar disorder	1.6e-05	0.000333	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—ADCY2—bipolar disorder	1.54e-05	0.00032	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—ADCY2—bipolar disorder	1.5e-05	0.000313	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—COMT—bipolar disorder	1.48e-05	0.000307	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—MAOA—bipolar disorder	1.47e-05	0.000305	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—ADCY2—bipolar disorder	1.42e-05	0.000295	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—CLOCK—bipolar disorder	1.34e-05	0.000279	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—COMT—bipolar disorder	1.32e-05	0.000274	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—MAOA—bipolar disorder	1.31e-05	0.000272	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—TSHB—bipolar disorder	1.31e-05	0.000272	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—TPH2—bipolar disorder	1.31e-05	0.000272	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—CACNB2—bipolar disorder	1.31e-05	0.000272	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—DPYD—bipolar disorder	1.29e-05	0.000268	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—COMT—bipolar disorder	1.29e-05	0.000268	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—MAOA—bipolar disorder	1.28e-05	0.000266	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—COMT—bipolar disorder	1.21e-05	0.000252	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—MAOA—bipolar disorder	1.21e-05	0.000251	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—CACNA1C—bipolar disorder	1.2e-05	0.000249	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—MTHFR—bipolar disorder	1.2e-05	0.000248	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—PIK3C2A—bipolar disorder	1.17e-05	0.000243	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—MTHFR—bipolar disorder	1.07e-05	0.000222	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—SNAP25—bipolar disorder	1.05e-05	0.000218	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—MTHFR—bipolar disorder	1.04e-05	0.000216	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—MTHFR—bipolar disorder	9.81e-06	0.000204	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—POMC—bipolar disorder	9.56e-06	0.000199	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—INS—bipolar disorder	9.51e-06	0.000198	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—ADCY2—bipolar disorder	9.27e-06	0.000193	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—POMC—bipolar disorder	8.53e-06	0.000177	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—INS—bipolar disorder	8.49e-06	0.000176	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—POMC—bipolar disorder	8.33e-06	0.000173	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—INS—bipolar disorder	8.28e-06	0.000172	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—COMT—bipolar disorder	7.94e-06	0.000165	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—MAOA—bipolar disorder	7.88e-06	0.000164	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—POMC—bipolar disorder	7.85e-06	0.000163	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—INS—bipolar disorder	7.81e-06	0.000162	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—MTHFR—bipolar disorder	6.42e-06	0.000133	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—POMC—bipolar disorder	5.13e-06	0.000107	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—INS—bipolar disorder	5.1e-06	0.000106	CbGpPWpGaD
